✦ LIBER ✦

352 Final Results of the First in Man Trial of MK4827, a Poly (ADP-ribose) Polymerase (PARP) Inhibitor with Antitumor Activity in BRCA Carriers and Sporadic Cancer Patients

✍ Scribed by Sandhu, S.K.; Wilding, G.; Schelman, W.R.; Omlin, A.; Kreischer, N.; Carpenter, C.; Iannone, R.; Kaye, S.; de-Bono, J.S.; Wenham, R.M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

362 First in human trial of a poly(ADP)-

✍ R.M. Wenham; S.K. Sandhu; G. Wilding; L. Sun; C. Toniatti; M. Stroh; C. Carpente 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 62 KB

First in human trial of the poly(ADP)-ri

✍ R. Wenham; G. Wilding; R. Baird; L. Sun; C. Toniatti; M. Stroh; C. Carpenter; J. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 71 KB

The poly(ADP-ribose) polymerase inhibito

✍ Sandhu, Shahneen K; Schelman, William R; Wilding, George; Moreno, Victor; Baird, 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 435 KB

Oral poly(ADP-ribose) polymerase inhibit

✍ Andrew Tutt; Mark Robson; Judy E Garber; Susan M Domchek; M William Audeh; Jeffr 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 594 KB

Oral poly(ADP-ribose) polymerase inhibit

✍ M William Audeh; James Carmichael; Richard T Penson; Michael Friedlander; Bethan 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 268 KB

A randomized, placebo-controlled trial t

✍ David A. Morrow; Chaim M. Brickman; Sabina A. Murphy; Kenneth Baran; Ricardo Kra 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 258 KB